We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Abbott Diagnostics

  Gold Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Long-Term Storage Stability of Corticotropin Investigated

By LabMedica International staff writers
Posted on 20 Dec 2021
Print article
Image: The ARCHITECT i2000SR automated immunoassay instrument system (Photo courtesy of Abbott Laboratories)
Image: The ARCHITECT i2000SR automated immunoassay instrument system (Photo courtesy of Abbott Laboratories)
Corticotropin (adrenocorticotropic hormone, ACTH) is a 39-residue polypeptide tropic hormone secreted by the anterior pituitary gland following hypothalamic corticotropin-releasing hormone release. Corticotropin is notorious for its instability.

Cortisol regulates ACTH release via a negative feedback loop. Measurements of plasma ACTH are crucial for differential diagnosis of endocrine disorders including Cushing’s syndrome and adrenal insufficiency but can be complicated by both preanalytical and analytical factors.

Clinical Biochemists at Amsterdam University (Amsterdam, The Netherlands) and their colleagues investigated the long-term storage stability of corticotropin in ethylenediaminetetraacetic acid containing plasma. Plasma specimens were obtained from 20 healthy American subjects that were either neat or spiked with ACTH (22–1,866 pg/ml). Plasma specimens were also obtained from Dutch patients visiting the Amsterdam University Medical Centers (UMC, Amsterdam, The Netherlands), between 2012 and 2013 for various indications.

Individual specimens were assayed on the day of processing (month 0) and five times (at 1, 3, 9, 12, and 18 months) following storage at both −20 °C and −70 °C in five replicates each. Specimens were thawed once on the laboratory countertop at room temperature, mixed by gentle inversion and centrifuged at 3,000×g for 5 minutes Afterwards they were kept at room temperature and quickly analyzed. ACTH results were generated on the ARCHITECT i2000SR automated immunoassay instrument system (Abbott Laboratories, Abbott Park, IL, USA). The team also used a chemiluminescence immunoassay (CLIA) that uses two monoclonal antibodies of which the Liaison capture antibody that is coated to magnetic particles and the detection antibody is linked to an isoluminol derivative (Diasorin, Salugia, Italy).

The team reported that storing human plasma specimens for up to one and a half years at −20 °C or −70 °C had limited influence on the ACTH levels in these specimens measured by the ARCHITECT ACTH assay. In both neat and spiked specimens at the two storage conditions, ACTH levels remained relatively stable over time with only minimal changes in ACTH levels (<11%). Storing specimens for up to four or six years did significantly reduce detectable ACTH levels in native patient plasma specimens. After four years of storage at −20 °C, ACTH levels were 74.8%, whereas after six years of storage ACTH levels were only 46.2% of the original ACTH levels measured using the Liaison immunoassay.

The authors concluded that corticotropin levels are stable in plasma when stored at −20 °C for one and a half years using the Abbott assay, but with longer storage time a significant reduction in corticotropin levels can be expected. Once specimens are stored for future corticotropin measurements, one should consider storage time, storage temperature and assay differences. The study was originally published on October 13, 2021 in the journal Clinical Chemistry and Laboratory Medicine.

Related Links:
Amsterdam University
Amsterdam University Medical Centers
Abbott Laboratories

Gold Supplier
SARS-CoV-2 Antigen Test
NG-Test SARS-NG-Test SARS-CoV-2 Ag Cassette
Automated Pathology Workstation
NanoMtrx 100 & 300
Automatic Photometer
Microplate Washer

Print article


Molecular Diagnostics

view channel
Image: This image depicts a DNA molecule that is methylated on both strands on the center cytosine. DNA methylation plays an important role for epigenetic gene regulation in development and cancer (Photo courtesy of Wikimedia Commons)

Study Supports Use of Methylated DNA Biomarkers for Cancer Diagnosis and Prognosis

A recent study added weight to the theory that methylated DNA biomarkers could be used for cancer diagnosis and prognosis. Methylation is a biological process by which methyl groups are added to a DNA molecule.... Read more


view channel
Image: Standard test for multiple myeloma provides clues of a rare, more deadly type (Photo courtesy of Pexels)

Standard Blood Cancer Test Provides Clues of Rare IgD Multiple Myeloma

IgD myeloma accounts for about 1% of common blood cancer multiple myeloma and has a worse prognosis. Specific testing for IgD myeloma is available at a handful of reference labs across the US, but takes... Read more


view channel
Image: QIAGEN has acquired a majority stake in enzymes provider BLIRT S.A. (Photo courtesy of QIAGEN)

Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business

QIAGEN N.V. (Venlo, Netherlands) has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A. (Gdansk, Poland), a manufacturer of recombinant enzymes for the life science industry.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.